Edesa Biotech, Inc.
EDSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001540159
No open-market purchases or sales by Edesa Biotech, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $30.0M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Edesa Biotech, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 22 | 2 | 28 | +8 |
| Shares | 3.05M | 37.7K | 2.64M | −371.3K (−12.3%) |
| Value | $4.34M | $54.6K | $13.8M | +$9.54M (+222.7%) |
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Edesa Biotech, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Perceptive Advisors LLC | 563,239 | $2.95M | 0.06% |
| Jane Street Group, LLC | 115,721 | $605.2K | 0.00% |
| Vanguard Capital Management LLC | 85,966 | $449.6K | 0.00% |
| Vanguard Fiduciary Trust Co | 38,446 | $201.1K | 0.00% |
| Commonwealth Equity Services, LLC | 35,003 | $183.1K | 0.00% |
| Scientech Research LLC | 30,534 | $159.7K | 0.13% |
| BlackRock, Inc. | 27,709 | $144.9K | 0.00% |
| Virtu Financial LLC | 26,275 | $137.0K | 0.01% |
| Schonfeld Strategic Advisors LLC | 19,650 | $102.8K | 0.00% |
| Scotia Capital Inc. | 15,843 | $82.9K | 0.00% |
| Northern Trust Corp | 14,994 | $78.4K | 0.00% |
| SBI Securities Co., Ltd. | 3,502 | $18.3K | 0.00% |
| McGuire Capital Advisors Inc | 1,500 | $7.84K | 0.01% |
| Citigroup Inc | 487 | $2.55K | 0.00% |
| Vanguard Global Advisers, LLC | 162 | $847 | 0.00% |
Sold out (7)
Institutions that held Edesa Biotech, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Nantahala Capital Management, LLC | 625,000 | $887.5K |
| DRW Securities, LLC | 134,222 | $190.6K |
| Citadel Advisors LLC | 53,630 | $77.8K |
| Diadema Partners LP | 54,025 | $76.7K |
| Persistent Asset Partners Ltd | 12,319 | $17.5K |
| Morgan Stanley | 2,300 | $3.27K |
| Bank of America Corp | 52 | $74 |
Not filed for Q1 2026 yet (2)
Institutions that held Edesa Biotech, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 37,600 | $54.5K |
| Global Retirement Partners, LLC | 86 | $122 |